Wpis z mikrobloga

Cześć. Przyszykowałem listę przedstawiającą najbardziej kontrowersyjne badania ery przed c19 wraz z patentami dotyczącymi technologii mrna i laboratoryjnej produkcji chimer. Ostatnia pozycja to patent firmy moderna z 2017 r, który patentuje ciąg 19 zasad mrna wirusa hiv w "celach onkologicznych" Całkiem przypadkowo ciąg ten występuje w kluczowym miejscu furin wirusa sars cov2:

Scientists Brace for Media Storm Around Controversial Flu Studies (20111123)
https://www.science.org/content/article/scientists-brace-media-storm-around-controversial-flu-studies?adobe_mc=MCMID%3D49833524091801333940576532631066892927%7CMCORGID%3D242B6472541199F70A4C98A6%2540AdobeOrg%7CTS%3D1678117798
https://www.science.org/content/article/exclusive-controversial-experiments-make-bird-flu-more-risky-poised-resume
Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward (20121009)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484390/
How A Tilt Toward Safety Stopped A Scientist's Virus Research (20141107)
https://www.npr.org/sections/health-shots/2014/11/07/361219361/how-a-tilt-toward-safety-stopped-a-scientists-virus-research
Capacity building efforts and perceptions for wildlife surveillance to detect zoonotic pathogens: comparing stakeholder perspectives (20140604)
https://pubmed.ncbi.nlm.nih.gov/24996851/
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (20151109)
https://www.nature.com/articles/nm.3985
Pierwsze badanie kliniczne szczepionki mrna (20170625)
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
https://pubmed.ncbi.nlm.nih.gov/28754494/
The proximal origin of SARS-CoV-2 (20220317)
https://www.nature.com/articles/s41591-020-0820-9

Patenty:
Methods for producing recombinant coronavirus
(Apl 20020419 patent 20071009)
https://patents.google.com/patent/US7279327B2/en

Methods and compositions for chimeric coronavirus spike proteins
(Apl 20150320 patent 20170406)
https://patents.google.com/patent/US20170096455A1/en
Prefusion coronavirus spike proteins and their use
(Apl 20171025 patent 20200227)
https://patents.google.com/patent/US20200061185A1/en
Combination PIV3/hMPV RNA vaccines
(Apl 20180720 patent 20190430)
https://patents.google.com/patent/US10272150B2/en

moderna oncology related
Modified polynucleotides for the production of oncology-related proteins and peptides
(apl 20160204 patent 20170307)
https://patents.google.com/patent/US9587003B2/en
MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site 20220221
CCU CGG CGG GCA CGU AG-3′ (nucleotides 23547-23565 in the SARS-CoV-2 genome, in which the four bold codons yield PRRA, amino acids 681–684 of its spike protein).
https://www.frontiersin.org/articles/10.3389/fviro.2022.834808/full

#covid19 #medycyna #nauka #grypa #ciekawostki